These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
556 related articles for article (PubMed ID: 8722747)
1. Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status. Tutera AM; Sellers TA; Potter JD; Drinkard CR; Wiesner GL; Folsom AR Genet Epidemiol; 1996; 13(2):207-21. PubMed ID: 8722747 [TBL] [Abstract][Full Text] [Related]
2. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL; Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391 [TBL] [Abstract][Full Text] [Related]
3. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013 [TBL] [Abstract][Full Text] [Related]
4. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Potter JD; Cerhan JR; Sellers TA; McGovern PG; Drinkard C; Kushi LR; Folsom AR Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):319-26. PubMed ID: 7655325 [TBL] [Abstract][Full Text] [Related]
5. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study. Gapstur SM; Potter JD; Drinkard C; Folsom AR Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):313-8. PubMed ID: 7655324 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for breast cancer according to estrogen and progesterone receptor status. Colditz GA; Rosner BA; Chen WY; Holmes MD; Hankinson SE J Natl Cancer Inst; 2004 Feb; 96(3):218-28. PubMed ID: 14759989 [TBL] [Abstract][Full Text] [Related]
8. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study. Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S; Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092 [TBL] [Abstract][Full Text] [Related]
9. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study. Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Wolk A Int J Cancer; 2006 Oct; 119(7):1683-9. PubMed ID: 16646051 [TBL] [Abstract][Full Text] [Related]
10. Relative weight at age 12 and risk of postmenopausal breast cancer. Bardia A; Vachon CM; Olson JE; Vierkant RA; Wang AH; Hartmann LC; Sellers TA; Cerhan JR Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):374-8. PubMed ID: 18250344 [TBL] [Abstract][Full Text] [Related]
11. Dietary fiber intake and risk of postmenopausal breast cancer defined by estrogen and progesterone receptor status--a prospective cohort study among Swedish women. Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Adlercreutz H; Wolk A Int J Cancer; 2008 Jan; 122(2):403-12. PubMed ID: 17764112 [TBL] [Abstract][Full Text] [Related]
12. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Bardia A; Olson JE; Vachon CM; Lazovich D; Vierkant RA; Wang AH; Limburg PJ; Anderson KE; Cerhan JR Breast Cancer Res Treat; 2011 Feb; 126(1):149-55. PubMed ID: 20669045 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374 [TBL] [Abstract][Full Text] [Related]
14. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. Sellers TA; Potter JD; Rich SS; Drinkard CR; Bostick RM; Kushi LH; Zheng W; Folsom AR J Natl Cancer Inst; 1994 Dec; 86(24):1860-5. PubMed ID: 7990161 [TBL] [Abstract][Full Text] [Related]
15. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis. Suzuki R; Orsini N; Saji S; Key TJ; Wolk A Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
17. Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Phipps AI; Buist DS; Malone KE; Barlow WE; Porter PL; Kerlikowske K; Li CI Breast Cancer Res Treat; 2011 Apr; 126(3):671-8. PubMed ID: 20814817 [TBL] [Abstract][Full Text] [Related]
18. Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors. Barnes BB; Steindorf K; Hein R; Flesch-Janys D; Chang-Claude J Cancer Epidemiol; 2011 Aug; 35(4):345-52. PubMed ID: 21159569 [TBL] [Abstract][Full Text] [Related]
19. Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis of epidemiological studies. Suzuki R; Orsini N; Mignone L; Saji S; Wolk A Int J Cancer; 2008 Apr; 122(8):1832-41. PubMed ID: 18067133 [TBL] [Abstract][Full Text] [Related]
20. Dietary fat and risk of breast cancer according to hormone receptor status. Kushi LH; Potter JD; Bostick RM; Drinkard CR; Sellers TA; Gapstur SM; Cerhan JR; Folsom AR Cancer Epidemiol Biomarkers Prev; 1995; 4(1):11-9. PubMed ID: 7894319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]